... purchased a new position in shares of Biohaven Pharmaceutical during the second quarter valued at about $790,000. Ardsley Advisory Partners purchased a new position in shares of Biohaven Pharmaceutical during the second quarter valued at about ...
https://www.americanbankingnews.com/2018/09/01/zacks-brokerages-anticipate-biohaven-pharmaceutical-holding-co-ltd-bhvn-to-post-1-08-earnings-per-share.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+AmericanBankingNews+%28American+Banking+News%29
No comments:
Post a Comment